Smoking cessation among tuberculosis patients during the coronavirus disease-2019 pandemic.

Smoking has been recognized as a significant risk factor for COVID-19 and mortality. The World Health Organization (WHO) has recommended smoking cessation to reduce the impact of COVID-19. This study aimed to evaluate the smoking cessation rate of patients starting tuberculosis (TB) treatment at six months using motivational interviewing based on the WHO "five steps to quit" model. In addition, we assessed the knowledge about smoking and the barriers to smoking cessation. We conducted a retrospective cohort study. Outpatients aged >18 years, smokers, and those who are starting TB treatment in two outpatient TB clinics were invited to participate. Patients received information about the importance of smoking cessation, especially in TB patients, and standardized advice based on guidelines. This information was repeated during phone calls during the second and fourth months of treatment. During the study period, 111 patients were included. The primary outcome was the smoking cessation rate at the end of the sixth month of treatment, which was 26.8% (19/71). The barriers to smoking cessation described by the patients were anxiety/depression (47.4%), seeing someone smoking (38.5%), drug use (19.2%), and alcohol abuse (2.6%). The assessment of knowledge about smoking showed that patients had some information gaps. In conclusion, TB smokers who tried to quit smoking during the COVID-19 pandemic faced many challenges. Despite this, we demonstrated a reasonable smoking cessation rate with a nurse-conducted motivational interview.

Impact of COVID-19 pandemic on tuberculosis and latent tuberculosis infection diagnosis in healthcare workers.

OBJECTIVES: To compare the prevalence of LTBI and TB in the pre-pandemic period (2017-2019) with the pandemic period (2020-2022), in a group of HCW. METHODS: Retrospective study. Data on TB diagnosis was retrieved from the hospital information system database. All HCWs who underwent tuberculin skin test (TST) from January 2017 to December 2022 were included in the study. RESULTS: In the pre-pandemic period (2017-2019), 163 HCW out of 710 were TST positive (22.9%), and in the pandemic period (2020-2022), 85 HCW out of 449 were TST positive (18.9%) (p = 0.11). There were 10 HCW diagnosed with TB in the pre-pandemic period (incidence: 41.7/100,000) and 2 in the pandemic period (incidence: 8.3/100,000) (p < 0.0001). CONCLUSIONS: This study showed that TB incidence was reduced during the pandemic period in HCW. TST positivity was also reduced, although not statistically significant.